LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus

An Open Therapeutic Observational Evaluation of the Efficacy and Safety Profile of Lantus in Everyday Medical Practice in Type 2 Diabetes Mellitus Patients, Who Start Receiving Lantus - Treated With Any Other Insulin, With A1c>7%

The objective of this protocol is to confirm the efficacy and safety profile of Lantus in every day medical practice, in type 2 diabetic patients, have been treated with any other insulin but who did not reach the target of A1c = 7%.

Inclusion Criteria:

• Patients with type 2 diabetes mellitus,
• Having been treated with any other insulin, but who did not reach the target of A1c=7%.
• Ability and willingness to perform Self Monitoring Blood Glucose measurement

Exclusion Criteria:

• Will follow the prescribing information (Summary of Product Characteristics).

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.